REDCARE PHARMACY NV (RDC.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:RDC • NL0012044747

68.4 EUR
+3.95 (+6.13%)
Last: Feb 5, 2026, 05:29 PM
Fundamental Rating

3

Taking everything into account, RDC scores 3 out of 10 in our fundamental rating. RDC was compared to 25 industry peers in the Consumer Staples Distribution & Retail industry. RDC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, RDC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • RDC had negative earnings in the past year.
  • RDC had a positive operating cash flow in the past year.
  • RDC had negative earnings in each of the past 5 years.
  • Of the past 5 years RDC 4 years had a positive operating cash flow.
RDC.DE Yearly Net Income VS EBIT VS OCF VS FCFRDC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • With a Return On Assets value of -2.88%, RDC is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
  • RDC has a worse Return On Equity (-7.01%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA -2.88%
ROE -7.01%
ROIC N/A
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
RDC.DE Yearly ROA, ROE, ROICRDC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

1.3 Margins

  • RDC has a Gross Margin of 22.88%. This is in the lower half of the industry: RDC underperforms 60.00% of its industry peers.
  • RDC's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for RDC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
RDC.DE Yearly Profit, Operating, Gross MarginsRDC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RDC has been reduced compared to 1 year ago.
  • The number of shares outstanding for RDC has been increased compared to 5 years ago.
  • Compared to 1 year ago, RDC has a worse debt to assets ratio.
RDC.DE Yearly Shares OutstandingRDC.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDC.DE Yearly Total Debt VS Total AssetsRDC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 3.30 indicates that RDC is not in any danger for bankruptcy at the moment.
  • RDC's Altman-Z score of 3.30 is fine compared to the rest of the industry. RDC outperforms 68.00% of its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that RDC is somewhat dependend on debt financing.
  • The Debt to Equity ratio of RDC (0.62) is better than 76.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 3.3
ROIC/WACCN/A
WACC6.68%
RDC.DE Yearly LT Debt VS Equity VS FCFRDC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • RDC has a Current Ratio of 1.68. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
  • RDC's Current ratio of 1.68 is amongst the best of the industry. RDC outperforms 92.00% of its industry peers.
  • RDC has a Quick Ratio of 1.23. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
  • RDC has a Quick ratio of 1.23. This is amongst the best in the industry. RDC outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.23
RDC.DE Yearly Current Assets VS Current LiabilitesRDC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The earnings per share for RDC have decreased strongly by -39.61% in the last year.
  • Looking at the last year, RDC shows a very strong growth in Revenue. The Revenue has grown by 26.68%.
  • The Revenue has been growing by 27.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%

3.2 Future

  • Based on estimates for the next years, RDC will show a very strong growth in Earnings Per Share. The EPS will grow by 52.00% on average per year.
  • RDC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.39% yearly.
EPS Next Y48.65%
EPS Next 2Y45.01%
EPS Next 3Y45.59%
EPS Next 5Y52%
Revenue Next Year25.07%
Revenue Next 2Y22.35%
Revenue Next 3Y20.54%
Revenue Next 5Y18.39%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RDC.DE Yearly Revenue VS EstimatesRDC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
RDC.DE Yearly EPS VS EstimatesRDC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RDC. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 345.14, the valuation of RDC can be described as expensive.
  • Based on the Price/Forward Earnings ratio, RDC is valued more expensive than 88.00% of the companies in the same industry.
  • RDC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.50.
Industry RankSector Rank
PE N/A
Fwd PE 345.14
RDC.DE Price Earnings VS Forward Price EarningsRDC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, RDC is valued more expensive than 84.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 36.25
RDC.DE Per share dataRDC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RDC does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as RDC's earnings are expected to grow with 45.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.01%
EPS Next 3Y45.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for RDC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

REDCARE PHARMACY NV

FRA:RDC (2/5/2026, 5:29:56 PM)

68.4

+3.95 (+6.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)01-07
Earnings (Next)N/A
Inst Owners51.62%
Inst Owner ChangeN/A
Ins Owners7.32%
Ins Owner ChangeN/A
Market Cap1.41B
Revenue(TTM)2.82B
Net Income(TTM)-35.19M
Analysts80
Price Target138.07 (101.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)150.51%
Min EPS beat(2)-12.8%
Max EPS beat(2)313.82%
EPS beat(4)2
Avg EPS beat(4)71.29%
Min EPS beat(4)-42.68%
Max EPS beat(4)313.82%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)-1.13%
Revenue beat(4)0
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)-0.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.22%
PT rev (3m)-12.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)39.28%
EPS NY rev (1m)-7.56%
EPS NY rev (3m)-1.52%
Revenue NQ rev (1m)-1.75%
Revenue NQ rev (3m)-2.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 345.14
P/S 0.5
P/FCF N/A
P/OCF 42.9
P/B 2.8
P/tB 14.13
EV/EBITDA 36.25
EPS(TTM)-1.75
EYN/A
EPS(NY)0.2
Fwd EY0.29%
FCF(TTM)-2.99
FCFYN/A
OCF(TTM)1.59
OCFY2.33%
SpS137.07
BVpS24.41
TBVpS4.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.88%
ROE -7.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.88%
FCFM N/A
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
F-Score3
Asset Turnover2.31
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA 8.5
Cap/Depr 136.74%
Cap/Sales 3.34%
Interest Coverage N/A
Cash Conversion 90.05%
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.23
Altman-Z 3.3
F-Score3
WACC6.68%
ROIC/WACCN/A
Cap/Depr(3y)87.99%
Cap/Depr(5y)151.24%
Cap/Sales(3y)2.78%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
EPS Next Y48.65%
EPS Next 2Y45.01%
EPS Next 3Y45.59%
EPS Next 5Y52%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%
Revenue Next Year25.07%
Revenue Next 2Y22.35%
Revenue Next 3Y20.54%
Revenue Next 5Y18.39%
EBIT growth 1Y-72.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year303.02%
EBIT Next 3Y93.89%
EBIT Next 5Y68.49%
FCF growth 1Y-2656.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.32%
OCF growth 3Y23.87%
OCF growth 5YN/A

REDCARE PHARMACY NV / RDC.DE FAQ

What is the ChartMill fundamental rating of REDCARE PHARMACY NV (RDC.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE.


Can you provide the valuation status for REDCARE PHARMACY NV?

ChartMill assigns a valuation rating of 1 / 10 to REDCARE PHARMACY NV (RDC.DE). This can be considered as Overvalued.


Can you provide the profitability details for REDCARE PHARMACY NV?

REDCARE PHARMACY NV (RDC.DE) has a profitability rating of 1 / 10.


What is the expected EPS growth for REDCARE PHARMACY NV (RDC.DE) stock?

The Earnings per Share (EPS) of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 48.65% in the next year.